Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at NUS have developed a new method that allows ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results